Pinto et al. [42] showed non-statistically significant improvements on imaging and Sino-Nasal Outcome Test (SNOT-20) measures after treatment with omalizumab and concluded that IgE only played a small role in the mucosal inflammation of CRS. Here, IGHE is linked to congenital rubella syndrome.